The Rel/NF-κB family:: friend and foe

被引:303
作者
Perkins, ND [1 ]
机构
[1] Univ Dundee, Dept Biochem, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland
关键词
D O I
10.1016/S0968-0004(00)01617-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The members of the Rel/NF-kappa B family of transcription factors form one of the first lines of defense against infectious diseases and cellular stress. These proteins initiate a highly coordinated response in multiple cell types that effectively counteracts the threat to the health of the organism, Conversely, disruption of the regulatory mechanisms that control the specificity and extent of this response, which results in aberrant activation of NF-kappa B, can be one of the primary causes of a wide range of human diseases. Thus, targeting NF-kappa B might lead to the development of new pharmaceutical reagents that could provide novel treatments for many inflammatory diseases and cancer.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 50 条
  • [1] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [2] Control of apoptosis by Rel/NF-κB transcription factors
    Barkett, M
    Gilmore, TD
    [J]. ONCOGENE, 1999, 18 (49) : 6910 - 6924
  • [3] Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases
    Barnes, PJ
    Larin, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) : 1066 - 1071
  • [4] Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
    Bondeson, J
    Foxwell, B
    Brennan, F
    Feldmann, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5668 - 5673
  • [5] Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis
    Bushdid, PB
    Brantley, DM
    Yull, FE
    Blaeuer, GL
    Hoffman, LH
    Niswander, L
    Kerr, LD
    [J]. NATURE, 1998, 392 (6676) : 615 - 618
  • [6] Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα
    Cabannes, E
    Khan, G
    Aillet, F
    Jarrett, RF
    Hay, RT
    [J]. ONCOGENE, 1999, 18 (20) : 3063 - 3070
  • [7] The Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
    Dechend, R
    Hirano, F
    Lehmann, K
    Heissmeyer, V
    Ansieau, S
    Wulczyn, FG
    Scheidereit, C
    Leutz, A
    [J]. ONCOGENE, 1999, 18 (22) : 3316 - 3323
  • [8] Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
    Epinat, JC
    Gilmore, TD
    [J]. ONCOGENE, 1999, 18 (49) : 6896 - 6909
  • [9] Foo SY, 1999, TRENDS GENET, V15, P229
  • [10] Genetic approaches in mice to understand Rel/NF-κB and IκB function:: transgenics and knockouts
    Gerondakis, S
    Grossmann, M
    Nakamura, Y
    Pohl, T
    Grumont, R
    [J]. ONCOGENE, 1999, 18 (49) : 6888 - 6895